Mass Vaccination in a Pandemic - Benefits versus Risks: Interview with Geert Vanden Bossche
Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research.
Coordinated Glob